Elanco Animal Health plans to acquire more than 40 vaccines from Boehringer Ingelheim Vetmedica Inc. in a transaction valued at $885 million, the companies announced today. The purchase consists of Boehringer’s entire U.S. portfolio of feline, canine and rabies vaccines and the company’s Fort Dodge, Iowa, manufacturing plant and laboratory. The agreement is subject to regulatory approval but is expected to conclude in early 2017. The deal follows a move late last year by parent company Boehringer Ingelheim to merge with veterinary drug maker Merial and sell most of Boehringer’s human drug business to Merial owner Sanofi S.A. The sale of the Fort Dodge facility to Elanco helps clear the way for the $5.2 billion Merial takeover, which is expected to close in the coming weeks. “This was a highly complex decision from a business and from an emotional perspective,” said Albrecht Kissel, president and CEO of St. Joseph, Mo.-based Boehringer Ingelheim Vetmedica. “We are confident that, under Elanco’s leadership, customers will continue to have access to these innovative vaccines and the portfolio will have strong support,” Kissel said. Boehringer would retain ownership of pet drugs such as Metacam and Vetmedin for dogs and Metacam and ProZinc for cats as well as cattle, equine and swine products. Elanco, headquartered in Greenfield, Ind., makes pharmaceuticals for companion animals and livestock. Its pet drugs include the spot-on feline flea preventive Cheristin and the canine flea and heartworm medication Trifexis. “As a result of the acquisition, Elanco will bring greater value to customers by providing a suite of options for preventing common diseases in companion animals,” said John C. Lechleiter, Ph.D., the president and CEO of Elanco owner Eli Lilly and Co. “Coupled with our robust food animal portfolio, this addition further strengthens Elanco’s position in the global animal health business,” Lechleiter added. Elanco would take possession of Boehringer’s newest offering: Ultra Duramune Lyme, a 0.5-milliliter Lyme disease vaccine for dogs, which was unveiled Tuesday. What Elanco Would Get Canine Duramune Line Duramune Max 5/4L Duramune Max 5 Duramune Max 5-Cvk/4L Duramune Max 5-Cvk Duramune Max Pv Duramune Cv-K Duramune Max PC Duramune Adult 3 LeptoVax 4 LeptoVax 4/C Canine Bronchi-Shield line Bronchi-Shield Oral Bronchi-Shield III Canine Duramune Lyme line Duramune Lyme Duramune Lyme + LeptoVax 4 Duramune Lyme + Max 5/4L Duramune Lyme + Max5-CvK/4L Duramune Lyme + Max5-CvK Duramune Lyme + Leptovax 4/C Canine Ultra Duramune line Ultra Duramune DAP+4L Ultra Duramune DAP Ultra Duramune 4L Ultra Duramune DAP+C4L Ultra Duramune DAP+C Ultra Duramune Lyme Feline Fel-O-Vax line Fel-O-Vax Lv-K IV + CaliciVax Fel-O-Vax Lv-K III + CaliciVax Fel-O-Vax Lv-K Fel-O-Vax IV + CaliciVax Fel-O-Vax PCT + CaliciVax Fel-O-Vax Lv-K + FIV Fel-O-Vax FIV CaliciVax Feline Ultra Fel-O-Vax line Ultra Fel-O-Vax FVRCP+FeLV Ultra Fel-O-Vax FVRCP Ultra Fel-O-Vax FeLV Ultra Fel-O-Vax Dual FCV Ultra Hybrid FVRCP Feline Fel-O-Guard line Fel-O-Guard Plus 3 Fel-O-Guard Plus 3 + Lv-K Fel-O-Guard Plus 4 Fel-O-Guard Plus 4 + Lv-K Rabies Rabvac 3 Rabvac 1
